Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair

Plastic and Reconstructive Surgery

Volumn 115, Issue 1, 2005, Pages 204-212

  Colwell, Amy S ^b   Beanes, Steven R ^b   Soo, Chia ^b   Dang, Catherine ^b   Ting, Kang ^b   Longaker, Michael T ^b   Atkinson, James B ^b   Lorenz, H Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN; HEPARIN BINDING PROTEIN; MITOGENIC AGENT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMIS; DOWN REGULATION; ENDOTHELIUM CELL; EXCISION; FEMALE; FETAL WOUND; FETUS; FETUS SURGERY; GESTATIONAL AGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SCAR FORMATION; SCARLESS WOUND REPAIR; SKIN DEVELOPMENT; STATISTICAL SIGNIFICANCE; WOUND HEALING;

ANIMALS; CICATRIX; FEMALE; FETAL PROTEINS; FETUS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; PREGNANCY; RATS; RNA, MESSENGER; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WOUND HEALING;

EID: 13244262625     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000138252.51581.22     Document Type: Article

References (45)

1. McGee, G. S., Broadley, K. N., Buckley, A., et al. Recombinant transforming growth factor beta accelerates incisional wound healing. Curr. Surg. 46: 103, 1989.
2. Pierce, G. F., Mustoe, T. A., Lingelbach, J., et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109: 429, 1989.
3. Mustoe, T. A., Pierce, G. F., Thomason, A., Gramates, P., Sporn, M. B., and Deuel, T. F. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237: 1333, 1987.
4. Brown, G. L., Curtsinger, L. J., White, M., et al. Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann. Surg. 208: 788, 1988.
5. Dvorak, H. F. VPF/VEGF and the angiogenic response. Semin. Perinatol. 24: 75, 2000.
6. Kroll, J., and Waltenberger, J. Regulation of the endothelial function and angiogenesis by vascular endothelial growth factor-A (VEGF-A). Z. Kardiol. 89: 206, 2000.
7. Fukumura, D., Xavier, R., Sugiura, T., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94: 715, 1998.
8. Larcher, F., Murillas, R., Bolontrade, M., Conti, C. J., and Jorcano, J. L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17: 303, 1998.
9. Senger, D. R., Van de Water, L., Brown, L. F., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12: 303, 1993.
10. Stephan, C. C., and Brock, T. A. Vascular endothelial growth factor, a multifunctional polypeptide. P. R. Health Sci. J. 15: 169, 1996.
11. Dvorak, H. F., Detmar, M., Claffey, K. P., Nagy, J. A., van de Water, L., and Senger, D. R. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107: 233, 1995.
12. Burgess, W. H., and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58: 575, 1989.
13. Neufeld, G., Cohan, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. F.A.S.E.B. J. 13: 9, 1999.
14. Olofsson, B., Pajusola, K., Kaipainen, A., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 93: 2576, 1996.
15. Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., and Erikkson, U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J. Biol. Chem. 271: 19310, 1996.
16. Joukov, V., Pajusola, K., Kaipainen, A., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGF-3) and KDR (VEGF-2) receptor tyrosine kinases. EMBO J. 15: 1751, 1996.
17. Chilov, D., Kukk, E., Taira, S., et al. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J. Biol. Chem. 272: 25176, 1997.
18. Achen, M. G., Jeltsch, M., Kukk, E., et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. U.S.A. 95: 548, 1998.
19. Kirkin, V., Mazitschek, R., Krishman, J., et al. Characterization of indolinones which preferentially inhibit VEGF-C and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. Eur. J. Biochem. 268: 5530, 2001.
20. Peters, K. G., De Vries, C., and Williams, L. T. Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. U.S.A. 90: 8915, 1993.
21. Corral, C.J., Siddiqui, A., Wu, L., Farrell, C. L., Lyons, D., and Mustoe, T. A. Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. Arch. Surg. 134: 200, 1999.
22. Nissen, N. N., Polverini, P. J., Koch, A. E., Volin, M. V., Gamelli, R. L., and DiPietro, L. A. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152: 1445, 1998.
23. Mackool, R. J., Rowe, N., Mehrara, B., et al. Excisional wound healing in the fetal rat. Surg. Forum 49: 463, 1998.
24. Beanes, S. R., Hu, F. Y., Soo, C., et al. Confocal microscopic analysis of scarless repair in the fetal rat: Defining the transition. Plast. Reconstr. Surg. 109: 160, 2002.
25. Dang, C. M., Beanes, S. R., Soo, C., et al. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast. Reconstr. Surg. 111: 1969, 2003.
26. Diaco, R. Practical considerations for the design of quantitative PCR assays. In M. A. Innis, D. H. Gelfand, and J. J. Sninsky (Eds.), PCR Strategies. San Diego, Calif.: Academic Press, 1995. Pp. 84-108.
27. Ankoma-Sey, V., Wang, Y., and Dai, Z. Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells. Hepatology 31: 141, 2000.
28. Howdieshell, T. R., Riegner, C., Gupta, V., et al. Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann. Surg. 228: 707, 1998.
29. Trompezinski, S., Pernet, I., Mayoux, C., Schmitt, D., and Viac, J. Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. Br. J. Dermatol. 143: 539, 2000.
30. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes: Implications for normal and impaired wound healing. J. Biol. Chem. 270: 12607, 1995.
31. Frank, S., Stallmeyer, B., Kampfer, H., Kolb, N., and Pfeilschifter, J. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. F.A.S.E.B. J. 13: 2002, 1999.
32. Hakvoort, T., Altun, V., van Zuijlen, P. P., de Boer, W. I., van Schadewij, W. A., and van der Kwast, T. H. Transforming growth factor-beta(1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur. Cytokine Netw. 11: 233, 2000.
33. Wojta, J., Kaun, C., Breuss, J. M., et al. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest. 79: 427, 1999.
34. Brauchle, M., Funk, J. O., Kind, P., and Werner, S. Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271: 21793, 1996.
35. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3: 211, 1992.
36. Weltermann, A., Wolzt, M., Petersmann, K., et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler. Thromb. Vasc. Biol. 19: 1757, 1999.
37. Williams, B., Baker, A. Q., Gallacher, B., and Lodwick, D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 25: 913, 1995.
38. Stavri, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., and Erusalimsky, J. D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia. Circulation 92: 11, 1995.
39. Stavri, G. T., Hong, Y., Zachary, I. C., et al. Hypoxia and platelet-derived growth factor-BB synergistically up-regulate the expression of vascular endothelial growth factor in vascular smooth muscle cells. F.E.B.S. Lett. 358: 311, 1995.
40. Li, J., Perrella, M. A., Tsai, J. C., et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J. Biol. Chem. 270: 308, 1995.
41. Wang, D., Huang, H. J., Kazlauskas, A., and Cavenee, W. K. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 59: 1464, 1999.
42. Salven, P., Manpaa, H., Orpana, A., Alitalo, K., and Joensuu, H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin. Cancer Res. 3: 647, 1997.
43. Ishii, Y. Expression and subtype analysis of vascular endothelial growth factor (VEGF) and its receptor (flt-1) in human ovarian tumors. Nippon Sanka Fujinka Gakkai Zasshi 47: 133, 1995.
44. Kim, K. J., Li, B., Winer, J., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841, 1993.
45. Lauer, G., Sollberg, S., Cole, M., et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115: 12, 2000.